COVID-19 disease. COVID-19, virus not identified
Conditions
Interventions
Intervention 1: Intervention group: The standard treatment regimen for COVID-19 along with a Ginger-based herbal medicine (Vomigone 500 mg tablets, registration number: 9406633051781240, Dineh Iran Ph
Sponsors
Bandare-abbas University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age =18 years Positive polymerase chain reaction (PCR) test for COVID-19 or/and lung involvement in imaging Primary clinical symptoms Hospitalized Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm
Exclusion criteria
Exclusion criteria: Underlying diseases, including chronic hepatitis, cirrhosis, cholestatic liver diseases, cholecystitis, and peptic ulcers Use of anticoagulant drugs like warfarin, and hormonal drugs History of allergy to ginger Pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SARS-CoV-2 clearance. Timepoint: Before intervention and day 7. Method of measurement: PCR test.;Fever. Timepoint: Before intervention and daily during the study. Method of measurement: Thermometer.;White blood cell count. Timepoint: Before intervention and day 7. Method of measurement: Labratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital admission. Timepoint: During the intervention. Method of measurement: Questionnaire.;Incidence of serious adverse events. Timepoint: Before intervention and daily during the study. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Fathalipour
Bandare-abbas University of Medical Sciences
Outcome results
None listed